Poly ICLC
(Redirected from Poly-ICLC)
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code | |
Identifiers | |
ChemSpider |
|
(verify) |
Poly ICLC is an immunostimulant. It is polyinosinic-polycytidylic acid (poly I:C) mixed with the stabilizers carboxymethylcellulose and polylysine.[1] It is under trial for use in cancer.[2]
Poly I:C is a ligand for toll like receptor-3, which usually triggers on the structurally similar double-stranded RNA present in some viruses.[1]
References
- ^ a b Zhu X, Nishimura F, Sasaki K, et al. (2007). "Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models". Journal of Translational Medicine. 5: 10. doi:10.1186/1479-5876-5-10. PMC 1802742. PMID 17295916.
- ^ "Intervention Dynamic Trial Listing Page". National Cancer Institute. 13 June 2017.
External links
- National Cancer Institute: poly ICLC
Categories:
- Chemicals that do not have a ChemSpider ID assigned
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugs that are a combination of chemicals
- Immunostimulants
- Combination drugs
- All stub articles
- Antineoplastic and immunomodulating drug stubs